Background: Cholesterol crystal embolism (CCE) is a serious complication of vascular procedures and based on the clinical features of patients with CCE, the aim of the present study was to establish screening criteria for aortic complex plaques (ACP) at high-risk of CCE.
holesterol crystal embolism (CCE) is a serious complication of vascular procedures such as angiography and cardiovascular surgery. Vulnerable aortic plaques are easily disrupted by mechanical contact during the procedure and induce embolization of cholesterol crystals. CCE causes a systemic inflammatory response that leads to multi-organ dysfunction. Effective therapy has not yet been established, and mortality from CCE is still high. 1, 2 It has been reported that detection of aortic complex plaques (ACP), which are the embolic source, contributes to prevention of stroke resulting from cardiovascular surgery. 3 We hypothesized that the same theory holds for CCE after catheterization procedures and designed the present studies to confirm this. First, we investigated whether patients with CCE have ACP and second, we evaluated whether patients with ACP tend to present with CCE after catheter-based procedures.
Our first study retrospectively evaluated the clinical characteristics and systemic plaque instability of patients with CCE, based on the ultrasound findings of the carotid arteries and aortic wall. Several reports show that patients with CCE have involvement of the carotid arteries as well as the aorta. 4, 5 We examined carotid plaque characteristics and confirmed that carotid complex plaques can be a surrogate marker of systemic instability of patients with CCE.
The second study was a prospective investigation of the relationship between ACP and CCE. In addition, we aimed to establish criteria for predicting ACP at high risk of leading to CCE. We recruited patients scheduled for catheterization procedures and performed blood tests and ultrasonographic evaluation of the carotid arteries and thoracic aorta. We explored the occurrence of CCE after the catheterization procedures and the factors associated with aortic plaque instability.
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On the basis of these results, we propose original criteria for predicting ACP.
Methods

First Study
Between April 2006 and June 2007, patients who presented with spontaneous symptoms of CCE at either outpatient examination or after left-heart catheterization were enrolled. We set the criteria of CCE according to a previous report, with some modification ( Table 1) . 1 Because patients with CCE frequently lack cutaneous signs, presence of skin lesions was not used as an essential criterion for the diagnosis of CCE. 6 Therefore, patients who presented with at least 2 of 3 symptoms including acute renal failure, skin involvement or hypereosinophilia within 2 weeks after a catheterization procedure or during a regular outpatient check-up were diagnosed as having CCE.
Second Study
We performed the second, prospective study between October 2007 and April 2009. Among patients admitted for catheterization procedures, 102 requiring transesophageal echocardiography (TEE) before catheterization were enrolled in the second study. Of these, 89 were scheduled for catheter ablation of atrial fibrillation and underwent exploration of left atrial thrombus before the procedure. The remaining 13 were selected from patients undergoing elective coronary angiography (CAG) or percutaneous coronary intervention (PCI) for ischemic heart disease. The condition of the aortic wall was being evaluated by TEE before catheterization because of concerns about either aortic involvement in a past history of cerebrovascular disease or multiple atherosclerotic factors. Written informed consent was given by all patients after receiving an explanation of the study.
Clinical Data
Patients' demographic information, atherosclerotic risk factors (hypertension, dyslipidemia, diabetes mellitus, current or former smoking, and obesity), comorbidities, procedures undergone, and outcomes of CCE were recorded. Hypertension was defined as systolic blood pressure (BP) ≥140 mmHg or diastolic BP ≥90 mmHg or use of antihypertensive drug therapy. Dyslipidemia was defined as total cholesterol ≥220 mg/dl, low-density lipoprotein (LDL)-cholesterol ≥140 mg/dl, highdensity lipoprotein cholesterol <40 mg/dl or the use of lipid-lowering agents. Diabetes mellitus was defined as a fasting serum glucose ≥126 mg/dl, non-fasting glucose ≥200 mg/dl, HbA1c level ≥6.5%, or the use of specific treatment. Body mass index (BMI) was calculated as body weight (kg) divided by height (m 2 ), with a BMI ≥25 considered to indicate obesity. The following were recorded for all patients at baseline: levels of high-sensitivity C-reactive protein (hs-CRP) and serum creatinine (s-Cre), blood eosinophil count (/ μl), and estimated glomerular filtration rate (eGFR), calculated as 0.741×175× age 0.203 ×s-Cre 1.154 ×(0.742 if female) ml · min -1 · 1.73 m −2 . Patients in the first study had these parameters recorded again after the onset of CCE. Patients in the second study underwent physical and blood examinations within 2 weeks of catheter procedures in the out patient clinic. Fulfilling the criteria shown in Table 1 was the basis for a diagnosed of CCE.
Ultrasound Evaluation
TEE examinations of the aorta were performed with a commercially available ultrasound system equipped with a 5-MHz transducer (Vivid 7, GE Healthcare, Horten, Norway or Aplio, Toshiba Medical Systems Co, Tochigi, Japan). TEE was performed 4±3 days after the diagnosis of CCE in the first study or on the day prior to catheterization in the second study. After local pharyngeal anesthesia, the patient was placed in the left lateral decubitus position, and the transducer was inserted. Following assessment of the cardiac chambers, the transducer was turned posteriorly and advanced to the distal esophagus, from where it was withdrawn to obtain horizontal images of the descending thoracic aorta and aortic arch. The transducer was subsequently rotated again and advanced to visualize the longitudinal plane of the ascending aorta. Changes in the aortic intima were classified according to a modification of criteria from a previous report. 7 The aortic wall was considered as plaque-free if the intimal surface was smooth and was <1 mm thick. A simple plaque was defined as having focally or linearly increased echo density of the intima. A complex plaque was defined as a protruding plaque >3 mm in thickness with ulceration and/or a mobile fragment on the plaque surface.
B-mode examinations of the carotid arteries were performed simultaneously by an ultrasound system (Aplio) with 7.5/10-MHz linear-array transducer. Patients were examined while supine. Scanning of each common carotid artery (CCA) began just above the clavicle and passed cephalically through the bifurcation as far distally as possible. The carotid intimamedia thickness (IMT) was defined as the distance from the leading edge of the lumen-intima interface of the far wall to the leading edge of the media-adventitia interface of the near wall. Plaques were defined as a widening of the vessel wall with IMT thickening >1.1 mm relative to the adjacent wall. Maximum IMT (max IMT) was defined as the greatest thickness measured on both sides of the CCA, bulbus and internal carotid artery, excepting the external carotid artery. Mean IMT was measured for both CCAs, excluding the bulbus, and was defined as the average of 3 points that included the point of max IMT and 2 points on either side (each 1 cm distant from the point of max IMT). The average of the mean IMT of both sides was recorded. Carotid plaques were analyzed for their echogenic composition, and surface characteristics, as in a previous study, 8 and were classified as complex when they had an irregular surface and/or a low echoic area and/or ulceration. A simple plaque was defined as a plaque with a smooth surface and homogeneous structure.
All ultrasonographic data were digitally stored and transferred to computer for off-line analysis, and each examination 
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was analyzed by 2 sonographers.
Original Criteria for Predict Aortic Complex Plaque
The analysis of the findings of the first and second studies revealed the clinical characteristics associated with ACP. We combined these clinical factors and created several models of the criteria to predict ACP. The second study population was evaluated with regard to whether they were at high-risk for complex plaques according to these models. Predictive accuracy for each model was calculated and the model showing the best sensitivity and specificity was finally selected.
Statistical Analysis
The data are expressed as mean ± SD or percentiles. We used the chi-square test or the Fisher's exact probability test for categorical variables and the Mann-Whitney U test or unpaired t-test for continuous variables. In the second study, all variables that were significantly associated with aortic vulnerable plaque in the univariate analysis were included in the multivariate models. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by multiple logistic regression analysis. Positive and negative predictive values were calculated according to Bayes' theorem. 9 We used SPSS (SPSS Inc, Chicago, IL, USA) and P<0.05 was considered to be statistically significant.
Results
Characteristics of Patients With CCE
In the first study, 10 patients were clinically diagnosed as Values are n (%) or mean ± SD. *P<0.05 vs baseline value; † P<0.01 vs baseline value. BMI, body mass index; CAD, coronary artery disease; CVD, cerebrovascular disease; hs-CRP, high-sensitivity C-reactive protein; s-Cre, serum creatinine; eGFR, estimated glomerular filtration rate; ND, not done; CAG, coronary angiography; PCI, percutaneous coronary intervention; CRF, chronic renal failure; HD, hemodialysis; IMT, intima-media thickness; Asc., ascending aorta; Dsc., descending aorta. Other abbreviation as in Table 1 .
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having CCE ( Table 2) . One patient (No. 8) had undergone routine hemodialysis before the catheterization procedure, so was excluded from the analysis of sCre and eGFR. In total, 8 of 10 patients presented with CCE after catheterization; the remaining 2 patients with spontaneous CCE had received continuous anticoagulation therapy for atrial fibrillation. It is worth noting that all patients had at least 3 atherosclerotic risk factors. One patient (No. 7) showed progressive renal failure and needed to begin hemodialysis. Two patients (Nos. 2, 6) died of multi-organ dysfunction, and histological confirmation of the diagnosis of CCE was obtained by autopsy. Notable findings were that hs-CRP, eGFR, and eosinophil count already showed altered levels before the catheterization procedures. The sCre concentration significantly increased and eGFR significantly decreased after CCE diagnosis (P=0.010, P=0.019, respectively). Post-procedural eosinophil counts and Figure. Schema of the results. First study retrospectively revealed the clinical characteristics of patients having CCE, which included the existence of ACP. Second study established the predictive criteria for ACP and prospectively presented the association between ACP and CCE. CCE, cholesterol crystal embolism; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; ACP, aortic complex plaque; TEE, transesophageal echocardiography.
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hs-CRP level also increased significantly (P=0.001, P=0.001, respectively).
The results of carotid and aortic ultrasound examinations are also shown in Table 2 . Carotid mean and max IMT increased in all patients. Except for 1 patient with simple plaque, carotid complex plaques were present in all patients. TEE revealed that all patients had complex plaque over the entire thoracic aorta. The main characteristics of patients with CCE are illustrated in Figure. 
Relationship of Aortic Complex Plaque to High Risk of CCE
In the second study, patients were divided into a noncomplex plaque group (no plaque/simple plaque, n=83) and a complex plaque group (n=19). The comparison of both groups is shown in Table 3 . Patients in the complex plaque group were older than those in the noncomplex group (P=0.013). Notably, the proportions of patients with diabetes and a smoking habit were higher in the complex plaque group (P<0.001, P=0.012, respectively). Patients in the complex plaque group also had a larger number of atherosclerotic risk factors (P<0.001).
The prevalence of patients with reduced eGFR, eosinophilia, and increased hs-CRP was higher in the complex group than in the noncomplex plaque group (P<0.001, P< 0.001, P=0.016, respectively). More patients in the complex group were scheduled for CAG or angioplasty for ischemic heart disease than in the noncomplex plaque group (P<0.001).
The prevalence of patients with carotid complex plaque was higher in the complex plaque group (P<0.001). The clinical features of patients in the complex plaque group were similar to those in the first study population who showed CCE.
Occurrence of CCE after catheterization was compared ( Table 3) . Patients without aortic complex plaque did not have CCE. On the other hand, 2 of 11 patients with aortic complex plaque were diagnosed as having CCE; 1 presented with blue toe syndrome and eosinophilia after PCI, and the other had eosinophilia and deterioration of renal function after catheter ablation. The rate of occurrence of CCE was significantly higher in the complex group (P=0.003). Univariate analysis revealed that eosinophilia (≥400 / μl), aortic complex plaque, and carotid complex plaque were associated with CCE (P=0.011, P=0.033, P=0.028, respectively).
Results of multivariate logistic regression analysis for aortic complex plaque are summarized in Table 4 . The presence of carotid complex plaques, eosinophilia (≥400 / μl), and multiple atherosclerotic risk factors (≥3) were identified as independent predictors of aortic complex plaque (OR 108, 95%CI 8.7-1,334, P<0.001; OR 164, 95%CI 5.0-5,434, P=0.004; OR 37, 95%CI 2.1-656, P=0.014; respectively).
Establishment of Original Predictive Criteria
The models of the combinations of clinical factors predicting aortic complex plaque are summarized in Table 5 . Model Values are n (%) or mean ± SD. Abbreviations as in Tables 1 and 2. MACHINO-OHTSUKA T et al.
1 consisted of independent predictors. Except for 1 patient, all patients with ACP had at least 3 atherosclerotic risk factors, so we set this as an essential criterion. We added in a stepwise manner each factor that showed a significant correlation with ACP on univariate analysis. The population of the second study was regrouped according to each model, and each model was evaluated for predictive accuracy.
From the results, we selected model 3 because it showed the highest sensitivity of all models and had better specificity than model 4. To achieve better specificity, we modified the model. We defined patients who presented with at least 3 of the 5 following criteria as being at "high-risk of ACP" ( Table 6 ): (1) multiple atherosclerotic risk factors (essential criterion), (2) carotid complex plaques, (3) hs-CRP ≥0.2 mg/dl, (4) eosinophil count ≥400 / μl, (5) eGFR ≤60 ml · min -1 · 1.73 m −2 . The accuracy of predicting ACP using these criteria is shown in Table 7 (P<0.001, chi-square test). The pretest likelihood of complex plaques is 19%, and our criteria predicted the presence of ACP with a sensitivity of 95%, specificity of 94%, positive predictive value of 79%, and negative predictive value of 99%. The likelihood ratio for detecting aortic complex plaque was 15.8.
Our combined criteria precisely recognized both patients with CCE in the second study as "high-risk". Therefore, our criteria had a sensitivity of 100%, specificity of 79%, positive predictive value of 8.7%, and negative predictive value of 100% for predicting CCE.
The results of the second study, including the prediction and existence of aortic complex plaque and occurrence of CCE, are summarized in Figure. 
Discussion
There are 5 major findings of the present study. Patients with CCE have (1) multiple atherosclerotic risk factors, elevated hs-CRP, reduced eGFR, and increased eosinophil count before CCE onset, (2) vulnerable complex plaques in the carotid artery as well as the aorta, and (3) similar characteristics to those of patients with complex aortic plaque; (4) they constitute a high proportion of those with complex aortic plaque, and (5) combined criteria including these features are useful for predicting ACP.
Prior Atherosclerotic Risk Factors and Pre-Procedural Laboratory Abnormalities
Common characteristics of patients with CCE have been revealed in previous reports. 1,2,10 They have a history of several ACP, aortic complex plaques; OR, odds ratio; CI, confidence interval. Table 4 . Table 6 . Predictive Criteria of ACP Abbreviations as in Tables 2 and 4 . Patients satisfying at least 3 of 5 criteria (criterion 1 is essential) are defined as being at "high-risk of ACP". Chi-square value =64.7, P<0.001. SE =95%; SP =94%; PP =79%; NP =99%; LR =15.8. Abbreviations as in Table 5 .
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atherosclerotic diseases, and their cardiovascular condition is unstable. Our patients with CCE had a history of atherosclerotic diseases and pre-procedural laboratory changes similar to those in the previous studies. 1, 2, 10 Patients with CCE (first study) and those with complex aortic plaques (second study) also had increased hs-CRP levels, eosinophil counts, and renal dysfunction above the normal range. It is widely recognized that continuous inflammation is iinvolved in the pathogenesis of atherosclerosis. Several large-scale studies have indicated that the hs-CRP level reflects the instability of atherosclerotic lesions and that it can be used as biomarker for risk stratification of cardiovascular events. [11] [12] [13] [14] According to a nationwide American survey that examined the population distribution of hs-CRP levels, the median level was 0.16 mg/dl, and hs-CRP ≥0.2 mg/dl indicated a significant increase in vascular risk. 15 Previous studies have also suggested that eosinophil counts >300 / μl are associated with increased vascular events. 16, 17 Siddiqui et al reported that eosinophilia (≥400 / μl) was independently associated with a large increase in the mortality of patients with chronic kidney disease (CKD) caused by atherosclerotic renal artery disease. 18 Increased eosinophil counts are also considered to reflect inflammation, although investigations into the detailed mechanism are still being performed.
CKD is tightly associated with cardiovascular events. 19, 20 Reduction of the eGFR to ≤60 ml · min -1 · 1.73 m −2 is a criterion of CKD. The patients with ACP in the current study fulfilled this criterion, with a high prevalence, and should be considered as a high-risk population.
Although CCE is basically an iatrogenic disease caused by aortic manipulation or the use of anticoagulants, there have been several reports of spontaneous occurrence without a preceding vascular procedure. 2, 21 Spontaneous and potential CCE is more frequent than is recognized, as shown by an autopsy study. 22 The CCE patients in the present study had some type of inflammation and renal dysfunction before their vascular procedures, which we consider to be a spontaneous, slight collapse of vulnerable aortic plaque leading to subclinical embolism.
Instability of Plaque in the Aorta Wall and Carotid Artery and High Risk of CCE
In our first study, TEE revealed that all patients with CCE had complex aortic plaque, as previously reported. 10 Our second study revealed that the existence of ACP significantly increases the rate of occurrence of CCE. Compared with past clinical studies, our patients with aortic complex plaque had a higher rate of CCE. 1, 2 These findings indicate that plaque instability and mechanical injury during vascular procedures may lead to plaque disruption and induce CCE. Our patients with CCE also had carotid plaques with similar vulnerable features as the aortic plaques. It is well known that cardiovascular events are associated with unstable plaque in the carotid arteries and thoracic aorta, [23] [24] [25] and we confirmed in the present study that vulnerable carotid plaques are a surrogate marker of systemic plaque instability.
Predictive Criteria of ACP
Our criteria were established to predict high-risk patients with aortic complex plaque on the basis of previous reports and the results of our current study. 1, 2 Every patient with CCE, with the exception of 1 patient who had aortic vulnerable debris, had at least 3 atherosclerotic risk factors, so we set this as the essential criterion. Next, we add the existence of carotid complex plaques and eosinophilia because they are significant independent predictors of ACP. We believe that high-risk patients with significant atherosclerotic involvement show systemic plaque instability and spontaneous erosion of plaques, which causes "subclinical CCE." However, the slight laboratory abnormalities caused by "subclinical CCE" are usually of no concern. Moreover, they can be generated by other causes, such as infection, allergy or other kidney disease. By combining the laboratory abnormalities with the clinical history and visible plaque instability in the carotid arteries, we can effectively distinguish patients with "subclinical CCE."
Clinical Implications
Various intensive treatments, such as LDL apheresis 26 and administration of corticosteroids, statins, and iloprost, [27] [28] [29] have been used for CCE; however, mortality still remains high. Detection of patients at high risk of CCE and taking precautions against it are therefore of great significance.
Results from the present study and past reports suggest an association between ACP and CCE. It is widely recognized that TEE can reveal aortic plaque and thus contribute to reducing the risk of embolism in various situations. 3, 30 For example, information about aortic plaque status and location may be helpful to determine the best vascular access site. Operators will be more careful with manipulation of catheters so that the aortic wall is not scraped. Revealing the signs of CCE risk may enable the physician to reconsider the necessity or timing of a vascular procedure.
To our knowledge, this is the first report of a simple method of screening high-risk patients with ACP. Although TEE can visualize aortic debris directly, it is invasive and causes distress to patients. Therefore, TEE is not practical on a routine basis for the risk assessment of all patients undergoing vascular procedures. Blood tests and carotid ultrasound are less invasive and more endurable for patients compared with TEE. Although the positive predictive value of our criteria is not so high, we consider our method as a tool for first-line screening. Screening must avoid missing high-risk patients, and the high sensitivity of our criteria adequately satisfies this purpose. We recommend that if the existence of risky aortic plaques is suspected on the basis of our criteria, TEE should be performed to confirm the condition of the aortic wall before any vascular procedures.
Study Limitations
There are 3 major limitations to the present study. First, histological diagnosis of CCE was performed in only 2 patients in the first study, and the remaining patients received only a clinical diagnosis. However, all patients had a possible predisposing factor for CCE, such as left heart catheterization or anticoagulation therapy, so we do not consider histological confirmation to be essential. Second, there were differences in the clinical characteristics of patients in the first and second studies. Most of patients in the first study underwent CAG or PCI and the majority of patients in the second study underwent ablation for atrial fibrillation. TEE causes some discomfort for patients, so it is not routinely indicated before CAG or PCI unlike before ablation for atrial fibrillation. However, it was desirable to unify the patients of both studies. Moreover, most of the second study population did not reflect the characteristics of the general population; that is, they were taking anticoagulants or antiplatelet agents, which might affect plaque composition. Therefore, further studies including patients without atrial fibrillation should be carried out to confirm our results. Third, because there were only 2 patients MACHINO-OHTSUKA T et al.
with CCE, the second study had a statistical limit to performing multivariate analysis for predictors of CCE. We require further prospective studies with a larger sample size to confirm that aortic complex plaque is an independent predictor of CCE.
Conclusion
Patients with CCE have multiple prior atherosclerotic diseases, renal dysfunction, eosinophilia, and higher hs-CRP before the onset of CCE. Patients with risky ACP show these same characteristics and have a higher rate of CCE than patients without complex plaques. Criteria that include these clinical features can highly predict ACP at high risk of CCE before vascular procedures.
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